Italian study tracks people with early type 1 diabetes risk markers
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study follows people of all ages who have a positive islet autoantibody test but no diabetes symptoms yet. It aims to track them over time to learn more about how type 1 diabetes develops, which may lead to better prevention and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have tested positive for at least one islet autoantibody (a blood marker linked with early type 1 diabetes)
- You do not have any symptoms of diabetes (like frequent urination, extreme thirst, or unexplained weight loss)
- Your blood sugar levels are not in the diabetes range (fasting glucose under 126 mg/dL, HbA1c under 6.5%, or 2-hour glucose under 200 mg/dL)
- You have not been previously diagnosed with type 1 or type 2 diabetes
- You are able to attend follow-up visits and provide consent (or a parent/guardian can for minors)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people with islet autoantibodies, which are early markers for type 1 diabetes. It aims to understand who develops these antibodies and how they are linked to diabetes over time. No treatment is given—you just provide blood samples and answer questions.
This study looks at using a finger-prick test instead of a standard blood draw for the oral glucose tolerance test (OGTT), which measures how your body handles sugar. It may help young people at risk for or with early type 1 diabetes avoid repeated needle sticks.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
This study looks for people at high risk of developing type 1 diabetes (based on family history or blood markers) and follows them over time to understand disease development. The goal is to eventually prevent or delay type 1 diabetes in people who don't have it yet.
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
Hear when a new Autoantibodies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.